Literature DB >> 22749866

Pre-administration of L-tryptophan improved ADR-induced early renal failure in mice.

Yuko Arioka1, Yasuko Yamamoto, Masato Hoshi, Keishi Matsumoto, Manabu Takamatsu, Akira Hara, Mitsuru Seishima, Kuniaki Saito.   

Abstract

AIMS: The aim of this study was to determine the localization of the rate-limiting enzyme indoleamine 2, 3-dioxygenase (IDO) and its metabolite in mice kidneys after adriamycin (ADR)-induced renal failure. We also examined the effect of L-tryptophan (Trp) administration on this model. MAIN
METHODS: BALB/c mice were treated with 15 mg/kg ADR to induce renal failure. The change of IDO and L-kynurenine (Kyn) following ADR-induced renal failure was examined by immunostaining combined with hematoxylin and eosin (HE) and Periodic acid-Schiff (PAS) staining for morphological analysis, and the concentration of L-Kyn was measured by HPLC. The effect of L-Trp administration on ADR-induced renal failure was also investigated. KEY
FINDINGS: Time-dependent increase of IDO immunostaining was observed in tubular cells from Day 4 after ADR injection. It was found that mice fed with L-Trp had less chance of renal failure at four days after ADR injection than mice untreated with L-Trp, but not at seven days. Further, L-Trp treatment significantly suppressed an increased level of TNF-alpha mRNA, but not of TGF-beta and IL1-beta after renal injury. SIGNIFICANCE: Local IDO expression in tubules was induced markedly after ADR- induced renal failure. L-Trp administration can be effective in suppressing ADR-induced renal failure at an early stage.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749866     DOI: 10.1016/j.lfs.2012.06.018

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Indoleamine 2, 3-dioxygenase (IDO) increases during renal fibrogenesis and its inhibition potentiates TGF-β 1-induced epithelial to mesenchymal transition.

Authors:  Luiz Henrique Gomes Matheus; Gislene Mendes Simão; Taíssa Altieri Amaral; Rodrigo Barbosa Oliveira Brito; Camila Soares Malta; Yves Silva Teles Matos; Alexandre Chagas Santana; Gabriela Gomes Cardoso Rodrigues; Maria Clara Albejante; Erna Elisabeth Bach; Maria Aparecida Dalboni; Cleber Pinto Camacho; Humberto Dellê
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

2.  Metabolomics study of fasudil on cisplatin-induced kidney injury.

Authors:  Demeng Xia; Xueli Lai; Kaiwen Wu; Panyu Zhou; Lei Li; Zhiyong Guo; Shuogui Xu
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.